Crossmark

Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol—non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospective, randomised controlled trial

Crossref DOI link: https://doi.org/10.1136/bmjopen-2018-024916

Published Online: 2019-01-29

Published Print: 2019-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Launonen, Antti P

Fjalestad, Tore

Laitinen, Minna K

Lähdeoja, Tuomas

Ekholm, Carl

Wagle, Tone

Mattila, Ville M
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03531463 at ClinicalTrials.gov

Documents that mention this clinical trial

Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol—non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospective, randomised controlled trial ^{(Pre-results)}
https://doi.org/10.1136/bmjopen-2018-024916

nct01246167 at ClinicalTrials.gov

Documents that mention this clinical trial

Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol—non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospective, randomised controlled trial
https://doi.org/10.1136/bmjopen-2018-024916

Document is current

Any future updates will be listed below